F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions

Health
By Christina Jewett and Apoorva Mandavilli from NYT Health https://ift.tt/BZfIs6L
via IFTTT Vaccination and Immunization, Coronavirus (2019-nCoV), Regulation and Deregulation of Industry The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda